Literature DB >> 8884033

Psychiatric manifestations of multiple sclerosis: a review.

J Rodgers1, R Bland.   

Abstract

OBJECTIVE: To report the occurrence, type, causes, and management of psychiatric manifestations in multiple sclerosis (MS).
METHOD: Review of recent, relevant literature.
RESULTS: Psychiatric illness, especially depression, occurs much more frequently than expected in patients with MS, is frequently unrecognized or ignored, and is treatable using standard methods, although patients with MS may be unusually sensitive to side effects of tricyclic antidepressants.
CONCLUSIONS: Research is needed to better define the causes of psychiatric syndromes in patients with MS. Those treating MS should increase their awareness of and sensitivity to the likelihood of psychiatric disorder in these patients.

Entities:  

Mesh:

Year:  1996        PMID: 8884033     DOI: 10.1177/070674379604100709

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  5 in total

1.  The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.

Authors:  N N Spirin; D S Kasatkin
Journal:  Neurosci Behav Physiol       Date:  2009-01

2.  Novel Antipsychotics in the Treatment of Behavioral Disturbances and Psychoses Associated With Neurodegenerative Disorders.

Authors:  Prakash S. Masand
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-06

3.  Mood Disorders in Neurologic Illness.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

Review 4.  The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.

Authors:  Ruth Ann Marrie; Stephen Reingold; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

5.  Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.

Authors:  Ruth Ann Marrie; John D Fisk; Bo Nancy Yu; Stella Leung; Lawrence Elliott; Patricia Caetano; Sharon Warren; Charity Evans; Christina Wolfson; Lawrence W Svenson; Helen Tremlett; James F Blanchard; Scott B Patten
Journal:  BMC Neurol       Date:  2013-02-06       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.